MALVX | RMFCX | MALVX / RMFCX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 25 years | 23 years | - |
Gain YTD | 3.472 | 4.836 | 72% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2000000 | 250 | 800,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 653M | 105B | 1% |
Annual Yield % from dividends | 1.49 | 1.69 | 88% |
Returns for 1 year | 2.63 | 11.03 | 24% |
Returns for 3 years | 10.68 | 19.69 | 54% |
Returns for 5 years | 16.81 | 41.75 | 40% |
Returns for 10 years | 54.08 | 64.83 | 83% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
ERHSX | 15.08 | -0.02 | -0.13% |
Eaton Vance Worldwide Health Sci R | |||
ISFIX | 17.67 | -0.33 | -1.83% |
VY® Columbia Contrarian Core I | |||
FNNEX | 63.42 | -1.36 | -2.10% |
American Funds New Economy 529-F-3 | |||
BRSSX | 14.32 | -0.35 | -2.39% |
MFS Blended Research Small Cap Eq R2 | |||
PSCHX | 22.77 | -0.63 | -2.69% |
PGIM Jennison Small Company R2 |